- Report
- November 2025
- 18 Pages
Nigeria
From €995EUR$1,210USD£905GBP
- Report
- October 2025
- 21 Pages
Singapore
From €995EUR$1,210USD£905GBP
- Report
- October 2025
- 90 Pages
Oman
From €4274EUR$4,850USD£3,754GBP
- Report
- October 2025
- 23 Pages
Italy
From €995EUR$1,210USD£905GBP
- Report
- October 2025
- 22 Pages
France
From €995EUR$1,210USD£905GBP
- Report
- October 2025
- 22 Pages
Saudi Arabia
From €995EUR$1,210USD£905GBP
- Report
- October 2025
- 25 Pages
Hong Kong, China
From €995EUR$1,210USD£905GBP
- Report
- October 2025
- 19 Pages
Denmark
From €995EUR$1,210USD£905GBP
- Report
- October 2025
- 89 Pages
Oman
From €4274EUR$4,850USD£3,754GBP
From €995EUR$1,210USD£905GBP
From €995EUR$1,210USD£905GBP
- Report
- September 2025
- 23 Pages
Germany
From €995EUR$1,210USD£905GBP
- Report
- September 2025
- 24 Pages
Canada
From €995EUR$1,210USD£905GBP
- Report
- September 2025
- 24 Pages
United Kingdom
From €995EUR$1,210USD£905GBP
- Report
- September 2025
- 22 Pages
Colombia
From €995EUR$1,210USD£905GBP
- Report
- March 2025
- 98 Pages
China
From €1586EUR$1,800USD£1,393GBP
- Report
- January 2025
- 23 Pages
India
From €995EUR$1,210USD£905GBP
- Report
- September 2021
- 19 Pages
Thailand
From €825EUR$1,003USD£750GBP
- Training
- 60 Minutes
Global
- Report
- March 2024
- 80 Pages
China
From €1586EUR$1,800USD£1,393GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more